Afficher la notice abrégée

dc.rights.licenseopenen_US
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorOUAALAYA, El Hassane
dc.contributor.authorFALQUE, L.
dc.contributor.authorDUPIS, J. M.
dc.contributor.authorSABATINI, M.
dc.contributor.authorBERNADY, A.
dc.contributor.authorNGUYEN, L.
dc.contributor.authorOZIER, A.
dc.contributor.authorNOCENT-EJNAINI, C.
dc.contributor.authorLE GUILLOU, F.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorMOLIMARD, Mathieu
dc.contributor.authorZYSMAN, M.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorRAHERISON-SEMJEN, Chantal
dc.date.accessioned2021-02-09T13:29:03Z
dc.date.available2021-02-09T13:29:03Z
dc.date.issued2020
dc.identifier.issn0954-6111en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/26189
dc.description.abstractEnIntroduction Exacerbations are key events in the natural history of COPD, but our understanding of their longitudinal determinants remains unclear. We used data from a large observational study to test the hypothesis that vaccination status and comorbidities could be associated with the occurrence of exacerbations profile. Methods Diagnosed COPD patients have been included by their pulmonologists, with up to 3 years of follow-up. Data were analyzed using the KmL method designed to cluster longitudinal data and receiver operating characteristic curve analysis to determine the best threshold to allocate patients to identified clusters. Results 932 COPD patients were included since January 2014, 446 patients (65.68% males, 35.59% current smokers) were followed over a period of 3 years with complete data. 239(28.15%) patients reported two or more exacerbations in the year before enrolment (frequent exacerbations). Among them 142(16.68%) also had frequent exacerbations in the first year of the study, and 69(8.10%) who remained frequent exacerbators in the second year. Based on our hypothesis, we were able to determine four phenotypes: A (infrequent), B (frequent in underweight patients), C (transient), and D (frequent in obese patients). Frequent exacerbators had more airflow limitation and symptoms. Irrespective of cut-offs set to define the optimal number of clusters, a history of exacerbations OR: 3.72[2.53–5.49], presence of anxiety OR: 2.03[1.24–3.31] and absence of the annual influenza vaccination OR: 1.97[1.20–3.24] remained associated with the frequent exacerbator phenotypes. Conclusions The most important determinants of frequent exacerbations are a history of exacerbations, anxiety and unvaccinated against influenza.
dc.language.isoENen_US
dc.subjectEPICENE
dc.subjectPharmacoEpi-Drugs
dc.title.enSusceptibility to frequent exacerbation in COPD patients: Impact of the exacerbations history, vaccinations and comorbidities?
dc.title.alternativeRespir Meden_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.rmed.2020.106018en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
bordeaux.journalRespiratory Medicineen_US
bordeaux.page106018en_US
bordeaux.volume169en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamPharmacoEpi-Drugsen_US
bordeaux.teamEPICENE_BPH
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03136069
hal.version1
hal.date.transferred2021-02-09T13:29:08Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Respiratory%20Medicine&rft.date=2020&rft.volume=169&rft.spage=106018&rft.epage=106018&rft.eissn=0954-6111&rft.issn=0954-6111&rft.au=OUAALAYA,%20El%20Hassane&FALQUE,%20L.&DUPIS,%20J.%20M.&SABATINI,%20M.&BERNADY,%20A.&rft.genre=article


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée